72.6 F
New York
Monday, May 17, 2021

ICON [NASDAQ: ICLR] Secures Multiple Categories in 2021 CRO Leadership Awards

Must read

Oaktree [NASDAQ: OCSL] Announces Pricing of Underwritten Public Offering

Oaktree Specialty Lending Corporation disclosed that it has set the price of an underwritten public offering of $350.0 million aggregate principal amount of...

Black.one Introduces Cryptocurrency Exchange Venture with $10B in Funding

Black.one has disclosed Tuesday that it has launched Bullish Global. Bullish Global is a subsidiary of Black.one. It is a new blockchain-based cryptocurrency exchange...

Pfizer-BioNTech COVID-19 Vaccine Gets FA Approval for Emergency Use in Adolescents

Pfizer Inc. and BioNTech SE disclosed that its COVID-19 vaccine has got the FDA approval for its COVID-19 vaccine. After the approval,...

Soliton [NASDAQ: SOLY] to be Acquired by Allergan Aesthetics

Soliton, Inc. disclosed Monday that it has inked an agreement with Allergen Aesthetics. As per the agreement, Allergen Aesthetics will buy Soliton. Allergen...

ICON Public Limited Company [NASDAQ: ICLR] has disclosed that it has won multiple categories in the annual CRO Leadership Awards. This is another greatest achievement for the firm as it has secured the award in the CRO Leadership Awards for the fifth consecutive award.

ICON has secured multiple categories earlier in 2020, 2019, 2018, and 2015. These awards are verification of ICON’s top-achieving scientific professionals and operational specialists. These award winners have demonstrated themselves to be the top service provider in each category.

Shares of ICON Public Limited Company [NASDAQ: ICLR] plunged 0.41% as it lost -0.83 during the trading session of Monday. The firm has recorded the price of $203.64. Looking at its liquidity, it has current ratio of 1.90 and a quick ratio of 1.90. ICON Public Limited market capitalization reached $10.79 billion at the time of writing.

Winning Categories

ICON has got the 2021 CRO Leadership Awards in five of the overall six categories. The six categories further divided into three groups Big Pharma, Small Pharma, and Overall. In two categories, ICON achieved awards in both the Big Pharma and Overall groups.

The six winning categories include Capabilities (Big Pharma), Compatibility (Overall, Big Pharma), Expertise (Big Pharma), Reliability (Big Pharma), and Quality (Overall, Big Pharma). The study’s partners were selected from pharma and biopharma firms of all sizes and were selected for decision-making authority compared to serving with contract research companies.

More articles

Latest article

Elon Musk’s SpaceX to Roll Out Dogecoin-Backed Satellite to the Moon in 2022

Elon Musk’s SpaceX has decided to recognize Dogecoin as payment to roll out its “DOGE-1 Mission to the Moon”. The mission is going to...

SBI CEO Yoshitaka Kitao Reveals Ripple to Go Public after its Legal Battle with the SEC is Over

CEO of Japanese financial services company SBI Holdings, Yoshitaka Kitao disclosed that Ripple has opted for an option to go public once its legal...

Coinbase Pro Announces it will be Listing Internet Computer’s ICP

Coinbase Pro cryptocurrency exchange has disclosed that it has decided to list ICP once it goes live. ICP is the governance token of the...

WISeKey [NASDAQ: WKEY] Gets Investment to finance its TrustNFT.IO NFT Platform

WISeKey International Holding AG disclosed Friday that it has inked a term-sheet to enter into an unsecured short-term loan and the issuance and...

Moderna [NASDAQ: MRNA] Inks Supply Agreement with Switzerland

Moderna, Inc. disclosed that it has inked a supply agreement on Thursday with the Swiss Federal Government. As per the agreement, Moderna Inc...

TeraBlock Will Have its Own BSCPad IDO Soon

TeraBlock which is a project making a platform for automated cryptocurrency portfolio management disclosed that it is preparing for an initial DEX offering (IDO)...

Why Chiasma [NASDAQ: CHMA] Stock is Skyrocketed?

Shares of Chiasma, Inc. surged 46.48% during the trading session of Wednesday. Chiasma has disclosed the financial results for the Q1 completed March...

NeoGenomics [NASDAQ: NEO] Announces Acquisition of Inivata Ltd

NeoGenomics, Inc. revealed Wednesday that it has decided to purchase Inivata Ltd. Inivata will grow into a liquid biopsy-centered division together with increasing...